Risk Factors for Cytomegalovirus Retinitis in a National Survey in Sweden

被引:4
作者
von Hofsten, Joanna [1 ,2 ]
Zetterberg, Madeleine [1 ,3 ]
机构
[1] Univ Gothenburg, Inst Neurosci & Physiol, Dept Clin Neurosci, Sahlgrenska Acad, Gothenburg, Sweden
[2] Halland Hosp Halmstad, Dept Ophthalmol, Halmstad, Sweden
[3] Sahlgrens Univ Hosp, Dept Ophthalmol, Molndal, Sweden
关键词
CMV retinitis; cytomegalovirus; diabetes mellitus; immunosuppression; intraocular inflammation; CLINICAL-FEATURES; IMMUNOCOMPROMISED PATIENTS; HIV; OUTCOMES; COHORT; ONSET;
D O I
10.1080/09273948.2022.2154679
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PurposeTo investigate predisposing immunosuppressive conditions causing cytomegalovirus retinitis (CMVr) and risk factors for delayed diagnosis in patients diagnosed between 2008 and 2018 in the Swedish population of 10 million.ResultsSixty-three consecutive patients (100 eyes) were diagnosed with CMVr. The most common immunosuppressive state predisposing for CMVr was hematopoietic stem cell transplant recipients (27%) and hematological malignancy (24%). Two patients (3.2%) had no other predisposing factor than diabetes mellitus (DM). Patients with delayed diagnosis (<= 30 days) were older than those with earlier diagnosis, mean age 68.7 (+/- 9.8) and 48.8 (+/- 17.6), respectively, p = .001. Signs of intraocular inflammation (IOI) were seen in 42 (70%) of cases and more common in delayed than early diagnosis, 16 (89%) and 21 (60%) respectively (p = .03).ConclusionDelayed diagnosis was more common in older individuals with signs of IOI. DM may be a risk factor for CMVr, and clinical signs can be mistaken for diabetic retinopathy.
引用
收藏
页码:485 / 492
页数:8
相关论文
共 38 条
[1]   Outcome of cytomegalovirus retinitis in immunocompromised patients without Human Immunodeficiency Virus treated with intravitreal ganciclovir injection [J].
Agarwal, Aniruddha ;
Kumari, Neha ;
Trehan, Amita ;
Khadwal, Alka ;
Dogra, Mangat R. ;
Gupta, Vishali ;
Sharma, Aman ;
Gupta, Amod ;
Singh, Ramandeep .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2014, 252 (09) :1393-1401
[2]  
[Anonymous], 1997, Am J Ophthalmol, V124, P141
[3]  
[Anonymous], National Patient Register [Internet]. [date unknown]
[4]  
Available from
[5]   Clinical Features of Newly Diagnosed Cytomegalovirus Retinitis in Northern Thailand [J].
Ausayakhun, Somsanguan ;
Keenan, Jeremy D. ;
Ausayakhun, Sakarin ;
Jirawison, Choeng ;
Khouri, Claire M. ;
Skalet, Alison H. ;
Heiden, David ;
Holland, Gary N. ;
Margolis, Todd P. .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2012, 153 (05) :923-931
[6]   Type 2 Diabetes and its Impact on the Immune System [J].
Berbudi, Afiat ;
Rahmadika, Nofri ;
Tjahjadi, Adi Imam ;
Ruslami, Rovina .
CURRENT DIABETES REVIEWS, 2020, 16 (05) :442-449
[7]   Natural Killer Cell Function, an Important Target for Infection and Tumor Protection, Is Impaired in Type 2 Diabetes [J].
Berrou, Jeannig ;
Fougeray, Sophie ;
Venot, Marion ;
Chardiny, Victor ;
Gautier, Jean-Francois ;
Dulphy, Nicolas ;
Toubert, Antoine ;
Peraldi, Marie-Noelle .
PLOS ONE, 2013, 8 (04)
[8]   Prognostic factors of survival of HIV-infected patients with cytomegalovirus disease: Aquitaine Cohort, 1986-1997 [J].
Binquet, C ;
Saillour, F ;
Bernard, N ;
Rougier, MB ;
Leger, F ;
Bonnal, F ;
Dabis, F .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2000, 16 (05) :425-432
[9]   Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults [J].
Bonten, M. J. M. ;
Huijts, S. M. ;
Bolkenbaas, M. ;
Webber, C. ;
Patterson, S. ;
Gault, S. ;
van Werkhoven, C. H. ;
van Deursen, A. M. M. ;
Sanders, E. A. M. ;
Verheij, T. J. M. ;
Patton, M. ;
McDonough, A. ;
Moradoghli-Haftvani, A. ;
Smith, H. ;
Mellelieu, T. ;
Pride, M. W. ;
Crowther, G. ;
Schmoele-Thoma, B. ;
Scott, D. A. ;
Jansen, K. U. ;
Lobatto, R. ;
Oosterman, B. ;
Visser, N. ;
Caspers, E. ;
Smorenburg, A. ;
Emini, E. A. ;
Gruber, W. C. ;
Grobbee, D. E. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (12) :1114-1125
[10]   Clinical features and outcomes of cytomegalovirus retinitis after transplantation [J].
Eid, A. J. ;
Bakri, S. J. ;
Kijpittayarit, S. ;
Razonable, R. R. .
TRANSPLANT INFECTIOUS DISEASE, 2008, 10 (01) :13-18